{"id":6584,"date":"2026-01-22T11:51:55","date_gmt":"2026-01-22T11:51:55","guid":{"rendered":"https:\/\/subject157.com\/?p=6584"},"modified":"2026-01-23T13:57:39","modified_gmt":"2026-01-23T13:57:39","slug":"selank-semax-bdnf-evidencia-claims-rotas","status":"publish","type":"post","link":"https:\/\/subject157.com\/pl\/selank-semax-bdnf-podkresla-trasy-roszczen\/","title":{"rendered":"Selank\/Semax i BDNF: dowody, twierdzenia i trasy (bez instrukcji)"},"content":{"rendered":"<!-- =========================================================\n     S157 JOURNAL \u2014 Semax vs Selank (Premium HTML | SEO + Links)\n     Block Editor: Custom HTML\n     ========================================================= -->\n\n<div class=\"s157-journal-premium\">\n\n  <!-- ABSTRACT -->\n  <div class=\"s157-jp-abstract\">\n    <div class=\"s157-jp-kicker\">ABSTRAKT<\/div>\n    <p>\n      Semax e Selank s\u00e3o frequentemente citados online como \u201cnootr\u00f3picos\u201d com impacto em <strong>BDNF<\/strong> e em estados afetivos\n      (stress\/ansiedade), mas a qualidade da conversa p\u00fablica costuma misturar: (1) achados pr\u00e9-cl\u00ednicos,\n      (2) estudos humanos com desenho limitado e (3) extrapola\u00e7\u00f5es de mecanismo como se fossem prova cl\u00ednica.\n      Este artigo faz uma leitura \u201cS157\u201d: separa evid\u00eancia de plausibilidade, define linguagem <em>YMYL-safe<\/em>,\n      i ramki <strong>trasy<\/strong> apenas como vari\u00e1vel farmacol\u00f3gica \u2014 <strong>bez<\/strong> instru\u00e7\u00f5es operacionais (\u201chow-to\u201d).\n      Para navega\u00e7\u00e3o, cruza com o <a href=\"https:\/\/subject157.com\/pl\/baza-danych-peptydow\/\">Baza danych peptyd\u00f3w<\/a>, o\n      <a href=\"https:\/\/subject157.com\/pl\/s157-leksykon-taktyczny-glosariusz\/\">Leksykon taktyczny<\/a> oraz\n      <a href=\"\/pl\/category\/journal\/\">Dziennik bada\u0144<\/a>.\n    <\/p>\n  <\/div>\n\n  <!-- INTEL LINKS -->\n  <div class=\"s157-jp-intel\">\n    <div class=\"s157-jp-intel-bar\"><\/div>\n    <div class=\"s157-jp-intel-head\">\n      <div class=\"s157-jp-kicker\">INTEL LINKS<\/div>\n      <p>\n        Links internos para reduzir \u201cnarrativa\u201d: defini\u00e7\u00f5es r\u00e1pidas, perfis de subst\u00e2ncias e ferramentas de verifica\u00e7\u00e3o documental.\n      <\/p>\n    <\/div>\n\n    <div class=\"s157-jp-grid-2\">\n      <div class=\"s157-jp-col\">\n        <h3>Podstawowe profile<\/h3>\n        <div class=\"s157-jp-cards\">\n          <a class=\"s157-jp-card\" href=\"https:\/\/subject157.com\/pl\/substances\/semax\/\">\n            <span class=\"s157-jp-card-t\">Semax<\/span>\n            <span class=\"s157-jp-card-s\">Perfil + notas de evid\u00eancia (mecanismo vs endpoint)<\/span>\n            <span class=\"s157-jp-pill\">Profil<\/span>\n          <\/a>\n\n          <a class=\"s157-jp-card\" href=\"https:\/\/subject157.com\/pl\/substances\/selank\/\">\n            <span class=\"s157-jp-card-t\">Selank<\/span>\n            <span class=\"s157-jp-card-s\">Claims comuns, limites de prova e riscos de extrapola\u00e7\u00e3o<\/span>\n            <span class=\"s157-jp-pill\">Profil<\/span>\n          <\/a>\n\n          <a class=\"s157-jp-card\" href=\"https:\/\/subject157.com\/pl\/baza-danych-peptydow\/\">\n            <span class=\"s157-jp-card-t\">Baza danych peptyd\u00f3w<\/span>\n            <span class=\"s157-jp-card-s\">Explorar por eixos: nootr\u00f3picos, stress, PK\/PD e evid\u00eancia<\/span>\n            <span class=\"s157-jp-pill\">Baza danych<\/span>\n          <\/a>\n        <\/div>\n      <\/div>\n\n      <div class=\"s157-jp-col\">\n        <h3>Framework &amp; Verifica\u00e7\u00e3o<\/h3>\n        <div class=\"s157-jp-cards\">\n          <a class=\"s157-jp-card\" href=\"https:\/\/subject157.com\/pl\/s157-leksykon-taktyczny-glosariusz\/\">\n            <span class=\"s157-jp-card-t\">Leksykon taktyczny<\/span>\n            <span class=\"s157-jp-card-s\">BDNF, nootr\u00f3pico, biodisponibilidade, onset\/dura\u00e7\u00e3o<\/span>\n            <span class=\"s157-jp-pill\">Leksykon<\/span>\n          <\/a>\n\n          <a class=\"s157-jp-card\" href=\"https:\/\/subject157.com\/pl\/narzedzia-laboratoryjne\/\">\n            <span class=\"s157-jp-card-t\">Narz\u0119dzia laboratoryjne<\/span>\n            <span class=\"s157-jp-card-s\">Koncepcje i kontrole (PK\/PD, stabilno\u015b\u0107, zmienno\u015b\u0107)<\/span>\n            <span class=\"s157-jp-pill\">Narz\u0119dzia<\/span>\n          <\/a>\n\n          <a class=\"s157-jp-card\" href=\"https:\/\/subject157.com\/pl\/audytor-coa\/\">\n            <span class=\"s157-jp-card-t\">Audytor kryminalistyczny COA<\/span>\n            <span class=\"s157-jp-card-s\">Rastreabilidade e red flags documentais (quando aplic\u00e1vel)<\/span>\n            <span class=\"s157-jp-pill\">COA<\/span>\n          <\/a>\n        <\/div>\n      <\/div>\n    <\/div>\n\n    <div class=\"subject157-note\">\n      <strong>Uwaga operacyjna (S157):<\/strong><br>\n      Conte\u00fado educativo. N\u00e3o \u00e9 aconselhamento m\u00e9dico nem guia de uso. Em YMYL, o objetivo \u00e9 reduzir dano:\n      evitar \u201cclaims\u201d absolutos, clarificar limites de prova e apontar para verifica\u00e7\u00e3o documental quando aplic\u00e1vel.\n      Para termos t\u00e9cnicos e defini\u00e7\u00f5es r\u00e1pidas, consulta o <a href=\"https:\/\/subject157.com\/pl\/s157-leksykon-taktyczny-glosariusz\/\">Leksykon<\/a>.\n    <\/div>\n  <\/div>\n\n  <h2>1) O problema: \u201cBDNF\u201d virou palavra m\u00e1gica<\/h2>\n  <p>\n    BDNF (<em>Czynnik neurotroficzny pochodzenia m\u00f3zgowego<\/em>) \u00e9 uma neurotrofina associada a plasticidade sin\u00e1ptica e adapta\u00e7\u00e3o neural.\n    No entanto:\n  <\/p>\n  <ul>\n    <li><strong>BDNF \u2260 cogni\u00e7\u00e3o garantida<\/strong>: um marcador pode subir sem traduzir benef\u00edcio robusto.<\/li>\n    <li><strong>Modelo animal \u2260 efeito humano<\/strong>: \u201caumentou BDNF em roedores\u201d n\u00e3o \u00e9 prova cl\u00ednica.<\/li>\n    <li><strong>Punkt ko\u0144cowy ma znaczenie<\/strong>: ansiedade, humor, mem\u00f3ria, fadiga e foco s\u00e3o dom\u00ednios diferentes.<\/li>\n  <\/ul>\n\n  <h2>2) Semax vs Selank: o que s\u00e3o (sem marketing)<\/h2>\n\n  <div class=\"s157-jp-table\">\n    <table>\n      <thead>\n        <tr>\n          <th>Zwi\u0105zek<\/th>\n          <th>Fam\u00edlia \/ narrativa comum<\/th>\n          <th>Co zwykle bada literatura<\/th>\n          <th>O que N\u00c3O \u00e9 leg\u00edtimo prometer<\/th>\n        <\/tr>\n      <\/thead>\n      <tbody>\n        <tr>\n          <td><strong><a href=\"https:\/\/subject157.com\/pl\/substances\/semax\/\">Semax<\/a><\/strong><\/td>\n          <td>Nootr\u00f3pico \/ neuro-modula\u00e7\u00e3o<\/td>\n          <td>Marcadores neurotr\u00f3ficos (incl. BDNF em certos contextos), stress, cogni\u00e7\u00e3o em desenhos espec\u00edficos.<\/td>\n          <td>\u201cAumenta QI\u201d, \u201ccura depress\u00e3o\u201d, \u201cfunciona sempre\u201d, \u201csem riscos\u201d.<\/td>\n        <\/tr>\n        <tr>\n          <td><strong><a href=\"https:\/\/subject157.com\/pl\/substances\/selank\/\">Selank<\/a><\/strong><\/td>\n          <td>Ansiol\u00edtico-pept\u00eddico \/ \u201cGABA-like\u201d (narrativa)<\/td>\n          <td>Ansiedade\/Stress, modula\u00e7\u00e3o comportamental, modelos de stress; por vezes men\u00e7\u00f5es a neurotrofinas.<\/td>\n          <td>\u201cSubstitui terap\u00eautica cl\u00ednica\u201d, \u201cefeito garantido\u201d, \u201czero efeitos adversos\u201d.<\/td>\n        <\/tr>\n      <\/tbody>\n    <\/table>\n  <\/div>\n\n  <div class=\"subject157-note\">\n    <strong>Z\u0142ota zasada S157:<\/strong><br>\n    \u201cMecanismo plaus\u00edvel\u201d \u00e9 uma pista \u2014 n\u00e3o \u00e9 prova. Um claim aceit\u00e1vel precisa de desenho humano, endpoint definido,\n    e coer\u00eancia entre estudos. Sem isso, usa linguagem condicional.\n  <\/div>\n\n  <h2>3) Evid\u00eancia: hierarquia e tradu\u00e7\u00e3o (animal \u2192 humano)<\/h2>\n  <p>Aby zachowa\u0107 \"czysto\u015b\u0107\" dyskursu naukowego, u\u017cywa on tej hierarchii (od najsilniejszej do najs\u0142abszej):<\/p>\n  <ol>\n    <li><strong>Badania na ludziach<\/strong> (randomizowane, kontrolowane, wyra\u017ane punkty ko\u0144cowe)<\/li>\n    <li><strong>Badania obserwacyjne na ludziach<\/strong> (associa\u00e7\u00e3o, n\u00e3o causalidade)<\/li>\n    <li><strong>Pr\u00e9-cl\u00ednico<\/strong> (roedores\/c\u00e9lulas: plausibilidade, n\u00e3o benef\u00edcio cl\u00ednico)<\/li>\n  <\/ol>\n\n  <div class=\"s157-jp-table\">\n    <table>\n      <thead>\n        <tr>\n          <th>N\u00edvel<\/th>\n          <th>Co mo\u017cna powiedzie\u0107 (YMYL-safe)<\/th>\n          <th>Czego unika\u0107<\/th>\n        <\/tr>\n      <\/thead>\n      <tbody>\n        <tr>\n          <td><strong>Cz\u0142owiek (dobry rysunek)<\/strong><\/td>\n          <td>\u201cEm ensaios com X popula\u00e7\u00e3o e Y dura\u00e7\u00e3o, observou-se\u2026\u201d<\/td>\n          <td>Generaliza\u00e7\u00f5es para todas as pessoas\/contextos<\/td>\n        <\/tr>\n        <tr>\n          <td><strong>Cz\u0142owiek (ograniczony)<\/strong><\/td>\n          <td>\u201cH\u00e1 sinais preliminares; precisa de replica\u00e7\u00e3o e desenho mais robusto.\u201d<\/td>\n          <td>\u201cEst\u00e1 provado\u201d, \u201c\u00e9 superior\u201d, \u201c\u00e9 seguro\u201d<\/td>\n        <\/tr>\n        <tr>\n          <td><strong>Zwierz\u0119 \/ in vitro<\/strong><\/td>\n          <td>\u201cSugere plausibilidade mecan\u00edstica; n\u00e3o demonstra benef\u00edcio cl\u00ednico.\u201d<\/td>\n          <td>Converter mecanismo em promessa terap\u00eautica<\/td>\n        <\/tr>\n      <\/tbody>\n    <\/table>\n  <\/div>\n\n  <h2>4) BDNF: marcador, n\u00e3o \u201ccertificado\u201d<\/h2>\n  <p>Nawet je\u015bli BDNF pojawia si\u0119 w wynikach:<\/p>\n  <ul>\n    <li><strong>Depende do m\u00e9todo<\/strong> (perif\u00e9rico vs central; timing de medi\u00e7\u00e3o).<\/li>\n    <li><strong>Pode ser epifen\u00f3meno<\/strong> (associado a mudan\u00e7as de comportamento\/sono\/exerc\u00edcio).<\/li>\n    <li><strong>N\u00e3o define magnitude cl\u00ednica<\/strong> (um aumento n\u00e3o implica um efeito percebido relevante).<\/li>\n  <\/ul>\n\n  <h2>5) Trasy (bez instrukcji): dlaczego pojawiaj\u0105 si\u0119 w rozmowie<\/h2>\n  <p>\n    Rotas s\u00e3o uma vari\u00e1vel de <strong>PK\/PD<\/strong> (absor\u00e7\u00e3o, onset, dura\u00e7\u00e3o, variabilidade). Aqui, o ponto \u00e9 apenas conceptual:\n  <\/p>\n\n  <div class=\"s157-jp-table\">\n    <table>\n      <thead>\n        <tr>\n          <th>Trasa (koncepcja)<\/th>\n          <th>Co mo\u017ce wp\u0142yn\u0105\u0107 na<\/th>\n          <th>Ryzyko nadmiernego roszczenia<\/th>\n        <\/tr>\n      <\/thead>\n      <tbody>\n        <tr>\n          <td><strong>Donosowo (IN)<\/strong><\/td>\n          <td>Onset e perfil de distribui\u00e7\u00e3o; variabilidade individual elevada.<\/td>\n          <td>\u201cVai direto ao c\u00e9rebro\u201d como certeza universal (simplifica\u00e7\u00e3o).<\/td>\n        <\/tr>\n        <tr>\n          <td><strong>Inne trasy<\/strong><\/td>\n          <td>Exposi\u00e7\u00e3o sist\u00e9mica vs local; tolerabilidade; consist\u00eancia de dose.<\/td>\n          <td>Transformar rota em promessa (\u201crota X = efeito garantido\u201d).<\/td>\n        <\/tr>\n      <\/tbody>\n    <\/table>\n  <\/div>\n\n  <div class=\"subject157-note\">\n    <strong>Wa\u017cne:<\/strong><br>\n    Este artigo n\u00e3o inclui instru\u00e7\u00f5es de utiliza\u00e7\u00e3o, prepara\u00e7\u00e3o, doses, frequ\u00eancia ou \u201cprotocolos\u201d.\n    Em S157, rotas s\u00e3o discutidas como vari\u00e1vel cient\u00edfica \u2014 n\u00e3o como guia operacional.\n  <\/div>\n\n  <h2>6) Claims comuns \u2014 e como \u201climpar\u201d (S157)<\/h2>\n\n  <div class=\"s157-jp-table\">\n    <table>\n      <thead>\n        <tr>\n          <th>Claim t\u00edpico (ru\u00eddo)<\/th>\n          <th>Vers\u00e3o S157 (segura e precisa)<\/th>\n          <th>Porqu\u00ea<\/th>\n        <\/tr>\n      <\/thead>\n      <tbody>\n        <tr>\n          <td>\u201cSemax aumenta BDNF, logo melhora mem\u00f3ria.\u201d<\/td>\n          <td>\u201cH\u00e1 estudos que exploram marcadores neurotr\u00f3ficos em contextos espec\u00edficos; isso n\u00e3o prova melhoria cognitiva generalizada.\u201d<\/td>\n          <td>Marcador \u2260 endpoint cl\u00ednico<\/td>\n        <\/tr>\n        <tr>\n          <td>\u201cSelank cura ansiedade.\u201d<\/td>\n          <td>\u201cAlguns trabalhos sugerem efeito ansiol\u00edtico em desenhos espec\u00edficos; \u00e9 preliminar e depende de popula\u00e7\u00e3o e metodologia.\u201d<\/td>\n          <td>Unikaj absolutyzmu YMYL<\/td>\n        <\/tr>\n        <tr>\n          <td>\u201cIN = direto ao c\u00e9rebro, sem risco.\u201d<\/td>\n          <td>\u201cIN pode alterar distribui\u00e7\u00e3o\/onset, mas h\u00e1 variabilidade e n\u00e3o elimina risco; n\u00e3o \u00e9 \u2018atalho\u2019 garantido.\u201d<\/td>\n          <td>Simplifica\u00e7\u00e3o enganadora<\/td>\n        <\/tr>\n      <\/tbody>\n    <\/table>\n  <\/div>\n\n  <h2>7) Kluczowe terminy (skr\u00f3ty do leksykonu)<\/h2>\n  <ul>\n    <li><a href=\"https:\/\/subject157.com\/pl\/s157-leksykon-taktyczny-glosariusz\/#bdnf\">BDNF<\/a> \u2014 neurotrofina e plasticidade (termo-chave, frequentemente abusado)<\/li>\n    <li><a href=\"https:\/\/subject157.com\/pl\/s157-leksykon-taktyczny-glosariusz\/#nootropico\">Nootropowy<\/a> \u2014 o que significa (e o que n\u00e3o significa)<\/li>\n    <li><a href=\"https:\/\/subject157.com\/pl\/s157-leksykon-taktyczny-glosariusz\/#biodisponibilidade\">Dost\u0119pno\u015b\u0107 biologiczna<\/a> \u2014 base para discutir \u201crotas\u201d sem magia<\/li>\n    <li><a href=\"https:\/\/subject157.com\/pl\/s157-leksykon-taktyczny-glosariusz\/#rotas-roa\">Trasy (ROA)<\/a> \u2014 vari\u00e1vel farmacol\u00f3gica<\/li>\n    <li><a href=\"https:\/\/subject157.com\/pl\/s157-leksykon-taktyczny-glosariusz\/#onset\">Pocz\u0105tek<\/a> \u2014 in\u00edcio de efeito (conceito)<\/li>\n    <li><a href=\"https:\/\/subject157.com\/pl\/s157-leksykon-taktyczny-glosariusz\/#duracao\">Czas trwania<\/a> \u2014 janela de efeito (conceito)<\/li>\n  <\/ul>\n\n  <h2>8) Related Database Profiles (6 cart\u00f5es internos)<\/h2>\n  <p>Para navegar do conceito para fichas concretas (sem \u201chow-to\u201d):<\/p>\n\n  <div class=\"subject157-related-grid\">\n    <div class=\"subject157-related-card\">\n      <strong><a href=\"https:\/\/subject157.com\/pl\/substances\/semax\/\">Semax<\/a><\/strong>\n      <small>Perfil e notas de evid\u00eancia (aten\u00e7\u00e3o \u00e0 diferen\u00e7a entre mecanismo e endpoint).<\/small>\n    <\/div>\n\n    <div class=\"subject157-related-card\">\n      <strong><a href=\"https:\/\/subject157.com\/pl\/substances\/selank\/\">Selank<\/a><\/strong>\n      <small>Enquadramento de claims e risco de extrapola\u00e7\u00e3o a partir de desenhos limitados.<\/small>\n    <\/div>\n\n    <div class=\"subject157-related-card\">\n      <strong><a href=\"\/pl\/substances\/bremelanotide-pt-141\/\">Bremelanotyd (PT-141)<\/a><\/strong>\n      <small>Contraste \u00fatil: eixo neurocomportamental \u2260 \u201cnootr\u00f3pico\u201d (evitar stacking por narrativa).<\/small>\n    <\/div>\n\n    <div class=\"subject157-related-card\">\n      <strong><a href=\"https:\/\/subject157.com\/pl\/substances\/diheksa\/\">Dihexa<\/a><\/strong>\n      <small>Bom para comparar \u201cplausibilidade mecan\u00edstica\u201d vs \u201cprova\u201d (risco de overclaim).<\/small>\n    <\/div>\n\n    <div class=\"subject157-related-card\">\n      <strong><a href=\"https:\/\/subject157.com\/pl\/substances\/oxytocin\/\">Oksytocyna<\/a><\/strong>\n      <small>Outro eixo afetivo\/social: ajuda a separar dom\u00ednios (endpoint importa).<\/small>\n    <\/div>\n\n    <div class=\"subject157-related-card\">\n      <strong><a href=\"https:\/\/subject157.com\/pl\/substances\/dsip\/\">DSIP<\/a><\/strong>\n      <small>Bom contraste para confusores de sono: marcador\/efeito percebido \u2260 causalidade.<\/small>\n    <\/div>\n  <\/div>\n\n  <h2>9) Checklist r\u00e1pido para n\u00e3o cair em overclaim<\/h2>\n  <ul>\n    <li>O estudo \u00e9 <strong>cz\u0142owiek<\/strong> i z jasnym punktem ko\u0144cowym?<\/li>\n    <li>BDNF foi medido onde e como? (perif\u00e9rico\/central; timing)<\/li>\n    <li>O texto diferencia \u201c<strong>wsp\u00f3\u0142pracownik<\/strong>\u201d de \u201c<strong>prowokuje<\/strong>\u201d?<\/li>\n    <li>H\u00e1 replica\u00e7\u00e3o e coer\u00eancia entre estudos?<\/li>\n    <li>Rotas s\u00e3o discutidas como PK\/PD \u2014 n\u00e3o como \u201catalho m\u00e1gico\u201d?<\/li>\n  <\/ul>\n\n  <div class=\"subject157-references\">\n    <h2>Referencje<\/h2>\n    <ol>\n      <li>Binder DK, Scharfman HE. <em>Czynnik neurotroficzny pochodzenia m\u00f3zgowego.<\/em> Growth Factors. (Revis\u00e3o base sobre BDNF).<\/li>\n      <li>Park H, Poo MM. <em>Neurotroficzna regulacja rozwoju i funkcji obwod\u00f3w nerwowych.<\/em> Nat Rev Neurosci. (Revis\u00e3o: neurotrofinas e plasticidade).<\/li>\n      <li>Revis\u00f5es e relat\u00f3rios acad\u00e9micos sobre Semax\/Selank e neuro-modula\u00e7\u00e3o (priorizar leitura cr\u00edtica do desenho, endpoint e popula\u00e7\u00e3o).<\/li>\n      <li>Artigos metodol\u00f3gicos sobre tradu\u00e7\u00e3o pr\u00e9-cl\u00ednico \u2192 humano e limita\u00e7\u00f5es de biomarcadores na infer\u00eancia cl\u00ednica.<\/li>\n    <\/ol>\n  <\/div>\n\n<\/div>\n\n<style>\n\/* =========================================================\n   S157 Journal Premium \u2014 Inline styles (safe)\n   - S\u00f3 estiliza s157-jp-* e wrappers de tabela\n   ========================================================= *\/\n.s157-journal-premium{\n  --ink:#0F172A;\n  --border:rgba(15,23,42,.10);\n  --teal:#00D6A0;\n  --cyan:#00C8FF;\n  --r22:22px;\n  --shadow:0 14px 34px rgba(15,23,42,.08);\n}\n\n.s157-jp-kicker{\n  font-size: 11px;\n  letter-spacing: .18em;\n  text-transform: uppercase;\n  color: rgba(15,23,42,.55);\n  font-weight: 900;\n  display:flex;\n  align-items:center;\n  gap:10px;\n  margin: 0 0 10px;\n}\n.s157-jp-kicker:before{\n  content:\"\";\n  width:6px;height:6px;border-radius:99px;\n  background: var(--teal);\n  box-shadow: 0 0 0 4px rgba(0,214,160,.14);\n}\n\n.s157-jp-abstract{\n  background: rgba(255,255,255,.92);\n  border: 1px solid var(--border);\n  border-radius: var(--r22);\n  box-shadow: var(--shadow);\n  padding: 16px 18px;\n  margin: 0 0 16px;\n}\n.s157-jp-abstract p{ margin: 0; color: rgba(15,23,42,.72); line-height: 1.65; }\n\n.s157-jp-intel{\n  background: rgba(255,255,255,.92);\n  border: 1px solid var(--border);\n  border-radius: var(--r22);\n  box-shadow: var(--shadow);\n  overflow: hidden;\n  margin: 0 0 18px;\n}\n.s157-jp-intel-bar{\n  height: 4px;\n  background: linear-gradient(90deg, rgba(0,214,160,.85), rgba(0,200,255,.80));\n}\n.s157-jp-intel-head{ padding: 14px 18px 0; }\n.s157-jp-intel-head p{ margin: 6px 0 0; color: rgba(15,23,42,.68); font-size: 13px; line-height: 1.6; }\n\n.s157-jp-grid-2{\n  display:grid;\n  grid-template-columns: 1.2fr 1fr;\n  gap: 14px;\n  padding: 14px 18px 18px;\n}\n.s157-jp-col h3{\n  margin: 8px 0 10px;\n  font-size: 14px;\n  font-weight: 900;\n  color: var(--ink);\n}\n.s157-jp-cards{ display:grid; gap:10px; }\n\n.s157-jp-card{\n  display:block;\n  border: 1px solid rgba(15,23,42,.10);\n  background: rgba(248,250,252,.74);\n  border-radius: 14px;\n  padding: 12px 14px;\n  text-decoration:none;\n  position: relative;\n  transition: transform .15s ease, box-shadow .15s ease, border-color .15s ease, background .15s ease;\n}\n.s157-jp-card:hover{\n  transform: translateY(-1px);\n  border-color: rgba(0,200,255,.28);\n  background: #fff;\n  box-shadow: 0 10px 22px rgba(15,23,42,.10);\n}\n.s157-jp-card-t{\n  display:block;\n  font-weight: 900;\n  color: var(--ink);\n  font-size: 13px;\n  line-height: 1.15;\n}\n.s157-jp-card-s{\n  display:block;\n  margin-top: 3px;\n  color: rgba(15,23,42,.62);\n  font-size: 12px;\n  line-height: 1.45;\n}\n.s157-jp-pill{\n  position:absolute;\n  top: 10px;\n  right: 10px;\n  font-size: 11px;\n  font-weight: 900;\n  padding: 6px 10px;\n  border-radius: 999px;\n  border: 1px solid rgba(15,23,42,.10);\n  background: rgba(255,255,255,.92);\n  color: rgba(15,23,42,.74);\n}\n\n.s157-jp-table{\n  overflow-x:auto;\n  -webkit-overflow-scrolling: touch;\n  border-radius: 14px;\n  border: 1px solid rgba(15,23,42,.08);\n  background: rgba(255,255,255,.86);\n  margin: 12px 0 14px;\n}\n.s157-jp-table table{ width:100%; border-collapse: collapse; min-width: 720px; }\n.s157-jp-table th, .s157-jp-table td{\n  padding: 12px 12px;\n  border-bottom: 1px solid rgba(15,23,42,.08);\n  vertical-align: top;\n  font-size: 13px;\n  line-height: 1.55;\n}\n.s157-jp-table th{\n  font-size: 11px;\n  letter-spacing: .14em;\n  text-transform: uppercase;\n  color: rgba(15,23,42,.60);\n  background: rgba(248,250,252,.9);\n}\n\n@media (max-width: 900px){\n  .s157-jp-grid-2{ grid-template-columns: 1fr; }\n  .s157-jp-table table{ min-width: 620px; }\n}\n<\/style>","protected":false},"excerpt":{"rendered":"<p>ABSTRACT Semax e Selank s\u00e3o frequentemente citados online como \u201cnootr\u00f3picos\u201d com impacto em BDNF e em estados afetivos (stress\/ansiedade), mas a qualidade da conversa p\u00fablica costuma misturar: (1) achados pr\u00e9-cl\u00ednicos, (2) estudos humanos com desenho limitado e (3) extrapola\u00e7\u00f5es de mecanismo como se fossem prova cl\u00ednica. Este artigo faz uma leitura \u201cS157\u201d: separa evid\u00eancia de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[10],"tags":[79,389,388,391,394,387,386,352,392,390,318,91,78,146,393,382],"class_list":["post-6584","post","type-post","status-publish","format-standard","hentry","category-journal","tag-bdnf","tag-claims","tag-evidencia","tag-intranasal","tag-journal","tag-neurociencia","tag-nootropicos","tag-pk-pd","tag-placebo","tag-rotas-de-administracao","tag-seguranca","tag-selank","tag-semax","tag-subject-157","tag-traducao-animal-humano","tag-ymyl"],"acf":[],"_links":{"self":[{"href":"https:\/\/subject157.com\/pl\/wp-json\/wp\/v2\/posts\/6584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/subject157.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/subject157.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/subject157.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/subject157.com\/pl\/wp-json\/wp\/v2\/comments?post=6584"}],"version-history":[{"count":0,"href":"https:\/\/subject157.com\/pl\/wp-json\/wp\/v2\/posts\/6584\/revisions"}],"wp:attachment":[{"href":"https:\/\/subject157.com\/pl\/wp-json\/wp\/v2\/media?parent=6584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/subject157.com\/pl\/wp-json\/wp\/v2\/categories?post=6584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/subject157.com\/pl\/wp-json\/wp\/v2\/tags?post=6584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}